Cargando…

Modified Zhibai Dihuang pill alleviated urinary tract infection induced by extended-spectrum β-lactamase Escherichia coli in rats by regulating biofilm formation

CONTEXT: Zhibai Dihuang pill (ZD), a traditional Chinese medicine nourishes Yin and reduces internal heat, is believed to have therapeutic effects on urinary tract infections (UTIs). OBJECTIVE: To explore the effects and mechanism of modified ZD (MZD) on UTI induced by extended-spectrum β-lactamase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kaifa, Zhu, Yongsheng, Su, Hongwei, Jiang, Hao, Liu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132235/ https://www.ncbi.nlm.nih.gov/pubmed/37096639 http://dx.doi.org/10.1080/13880209.2023.2199786

Ejemplares similares

Zhibai Dihuang Pill Alleviates Ureaplasma urealyticum-Induced Spermatogenic Failure and Testicular Dysfunction via MAPK Signaling Pathway
por: Zhang, Kai, et al.
Publicado: (2022)

Retracted: Zhibai Dihuang Pill Alleviates Ureaplasma urealyticum-Induced Spermatogenic Failure and Testicular Dysfunction via MAPK Signaling Pathway
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Nephroprotective Role of Zhibai Dihuang Wan in Aristolochic Acid-Intoxicated Zebrafish
por: Lu, Ping-Hsun, et al.
Publicado: (2020)

Potential Molecular Mechanisms of Zhibai Dihuang Wan in Systemic Lupus Erythematosus Based on Network Biology
por: Yang, Zi, et al.
Publicado: (2020)

Effectiveness of Zhibai Dihuang pill (Chinese herbal formula) in combination with western drugs in the treatment of recurrent aphthous stomatitis: A systematic review and meta-analysis
por: Peng, Shuang-li, et al.
Publicado: (2023)

Exploring the Mechanism of Zhibai Dihuang Decoction in the Treatment of Ureaplasma Urealyticum-Induced Orchitis Based on Integrated Pharmacology
por: Bin, Dong-hua, et al.
Publicado: (2021)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats
por: Liu, Chang-Ming, et al.
Publicado: (2018)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Esteve-Palau, Erika, et al.
Publicado: (2018)

Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: TÜZÜN, Türkan, et al.
Publicado: (2019)

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)

Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019)

Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report
por: Fischer, Aaron, et al.
Publicado: (2021)

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase–Producing Escherichia coli Urinary Tract Infections in France
por: Paumier, Adeline, et al.
Publicado: (2022)

Characteristics of Dogs with Biofilm‐Forming Escherichia Coli Urinary Tract Infections
por: Kern, Zachary T., et al.
Publicado: (2018)

Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)

Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
por: Wang, Xiqoqiang, et al.
Publicado: (2023)

Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time
por: Picozzi, Stefano C. M., et al.
Publicado: (2014)

Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya
por: Abujnah, Abubaker A., et al.
Publicado: (2015)

Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections
por: Spadafino, Joseph T, et al.
Publicado: (2014)

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species
por: Koksal, Eda, et al.
Publicado: (2019)

Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review
por: Larramendy, Stéphanie, et al.
Publicado: (2020)

Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco
por: Kettani Halabi, Mohamed, et al.
Publicado: (2021)

Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal
por: Shrestha, Raju, et al.
Publicado: (2019)

Effect of Lactobacillus plantarum Biofilms on the Adhesion of Escherichia coli to Urinary Tract Devices
por: Carvalho, Fábio M., et al.
Publicado: (2021)

Incidence and molecular characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in Eastern Saudi Arabia
por: Mashwal, Fahad A., et al.
Publicado: (2017)

Increased Isolation of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Community-Onset Urinary Tract Infection Cases in Uttarakhand, India
por: Kumar, Nitin, et al.
Publicado: (2021)

In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia
por: Ngoi, Soo Tein, et al.
Publicado: (2021)

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection
por: DeBusscher, Joan, et al.
Publicado: (2009)

The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications
por: Zhao, Yue, et al.
Publicado: (2016)

Simultaneous Determination of the Five Constituents in Maiwei Dihuang Pills by the HPLC-DAD Method
por: Jia, Danchun, et al.
Publicado: (2021)

CTX-M β-Lactamases in Escherichia coli from Community-acquired Urinary Tract Infections, Cambodia
por: Ruppé, Etienne, et al.
Publicado: (2009)

Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection
por: Moayednia, Reza, et al.
Publicado: (2014)

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran
por: Pakzad, Iraj, et al.
Publicado: (2011)

Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children
por: Polat, Meltem, et al.
Publicado: (2017)

Frequency of quinolone resistance genes among extended-spectrum β-lactamase (ESBL)-producing Escherichia coli strains isolated from urinary tract infections
por: FarajzadehSheikh, Ahmad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4d2t3a5c5hg2kd0sfqn4ljfbij